wireless thermal anisotropy measurement device
DeviceWireless wearable thermal anisotropy measurement device designed for use at home will be provided to study subjects in both study arms
NCT Number: NCT07050628
This study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow over multiple measurements performed by a study subject during activities of daily living and sleep
Interested in participating?
Request Info2 year and older
All sexes
Interventional
Not applicable
Rhaeos Inc., Chicago, Illinois, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Wireless wearable thermal anisotropy measurement device designed for use at home will be provided to study subjects in both study arms
Time frame: 30 days
The co-primary endpoints in this study are the rate of ADEs and SADEs that occur per wear hour.
Time frame: 30 days
rate of ADEs and SADEs per wear period
Time frame: 30 days
rate of ADEs and SADEs per subject;
Time frame: 30 days
rate of ADEs and SADEs that preclude the continued use of the study device
Time frame: 30 days
percent of device deficiencies resulting in incomplete monitoring data
Time frame: 30 days
number of local skin reactions per wear session;
Time frame: 30 days
usability score based on post-study survey (1 = easy to use; 5 = difficult to use)
Contact information is provided by the study sponsor or research team.
Rhaeos, Inc.
Industry
Long-Term Tracking of Fluid Dynamics in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device During Activities of Daily Living Including Sleep
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06253858
Brain Diseases, Central Nervous System Diseases
Hershey, Pennsylvania, United States
View Trial DetailsNCT05910944
Brain Diseases, Central Nervous System Diseases
Kuopio, Finland
View Trial DetailsNCT06724029
Aneurysm, Aneurysms
Bergamo, BG, Italy
View Trial DetailsNCT05546996
Brain Diseases, Central Nervous System Diseases
Houston, Texas, United States
View Trial Details